Endostar, a Modified Recombinant Human Endostatin, Suppresses Angiogenesis through Inhibition of Wnt/β-Catenin Signaling Pathway

Endostar, a novel modified recombinant human endostatin, is now widely studied for the treatment of diseases that are characterized or caused by pathological angiogenesis. However, its molecular mechanism remains unclear. In this study, we investigated the effects of Endostar on the Wnt/β-catenin si...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Xiaoming, Mao, Wei, Chen, Qian, Zhuang, Qin, Wang, Lihui, Dai, Jin, Wang, Haibing, Huang, Zhaoquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4169397/
https://www.ncbi.nlm.nih.gov/pubmed/25232946
http://dx.doi.org/10.1371/journal.pone.0107463

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4169397/
https://www.ncbi.nlm.nih.gov/pubmed/25232946
http://dx.doi.org/10.1371/journal.pone.0107463

Ejemplares similares